Combined blockade of B7-H3 and PD-L1 (10), elimination of MDSCs in the tumor microenvironment (46), and blockade of TIGIT (51) (T cell immunoglobulin and ITIM domain protein) can all partially restore NK cell activity and function. This evidence concerns the gene CD274 and neoplasm.